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INTRODUCTION:  Metastases  to  the breast  from  extra-mammary  tumors  are  uncommon  and  few  sporadic
cases  are  reported  in  the  international  literature.  An  accurate  differential  diagnosis  of  secondary  cancer
is  mandatory  because  both  prognosis  and  treatment  differ  with  respect  to primary  breast  tumors.
PRESENTATION OF  CASE:  We  present  the case  of  a 70-year-old  woman  with  an  isolated  metastasis  to  the
breast  occuring  9 years  after  undergoing  a nephrectomy  for Renal  Cell  Carcinoma  (RCC).
Clinical  examination  revealed  a palpable  and  mobile  mass  in  the  right  breast  with  an  enlarged  ipsilateral
axillary  lymph  node.  Mammographic  ﬁndings  showed  a dense,  well  circumscribed  solid  mass  and  the
breast  ultrasonography  ﬁndings  were  those  of  a hypoechoic  homogeneous  solid  nodule  with no  posterior
attenuation  but  with  prominent  peripheral  vascularity.  A tru-cut  biopsy  was  conclusive  for  a metastatic
deposit  by  RCC.  A whole-body  CT  scan  showed  no  evidence  of  further  recurrences.  The patient  underwent
metastasectomy  and  exeresis  of  the  papable  lymphnode.
DISCUSSION: In patients  with  former  surgery  for RCC, a diagnosis  based  on  a  preoperative  biopsy  allows
to  indicate  the  proper  surgical  treatment:  in  facts,  as compared  to  primary  breast  tumors  treatment,  the
rationale  to  pursue  wide  surgical  margins  is  pointless  in cases  of  metastases  and,  similarly,  the  biopsy  of
the  sentinel  lymphnode  is  void  of sense  due  to the  lack  of  its  physiopathological  prerequisite.
CONCLUSION: We  suggest  to consider  a micro-histological  biopsy  of  any  new  breast  lesion  appearing  in  a
reatm
lished
D licenpatient  with  a history  of t
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. Introduction
Renal Cell Carcinoma (RCC) is the third most common genitouri-
ary tract tumor.1 It accounts for approximately 3% of all adult
eoplasms and in about 30% of patients it has a tendency to metas-
asize, usually to the lung (70%), lymph-nodes (55%), bone (42%),
iver (41%), adrenal gland (15%) and brain (11%).1–4
Breast metastases from extra-mammary tumors are much less
ommon with respecto to primary breast tumors (0.5–2% of breast
ancer),5–8 and are usually due to melanoma, lymphoma and
eukemia9; metastases to the breast from RCC are a rare occurrence
nd take place in 3% of all metastatic RCC.10 Overall, 25 such cases
Open access under CC BY-NC-Nave been reported in the literature: eleven cases presented with
etastasis as the initial sign of the disease and fourteen, among
hich 2 were bilateral, occurred as metachronous lesions after
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a former nephrectomy.3,4,11–17 We report a case of RCC metasta-
sis to the breast occurring 9 years after primary surgery for RCC.
The difﬁculties in obtaining a correct diagnosis, which is crucial to
avoid unnecessary mastectomy, and the management of axillary
ipsilateral axillary lymph nodes are discussed.
2. Presentation of case
A  70-year-old woman was  referred to our institution on April
2013 due to a quickly enlarging lump located in the upper inner
quadrant of her right breast. In her medical history, she reported
having undergone a right radical nephrectomy in 2004 for RCC. At
the time of the operation the tumor was limited to the kidney com-
pressing the renal capsule but with no sign of inﬁltration and there
was no vascular invasion as well; surgical margins were free and the
disease was therefore staged as T3N0M0 (G2). The patient received
no further treatment and was  followed up with annual whole-body
computed tomography (CT) scan and MRI. In april 2011 she under-
went a pylorus-preserving pancreatic head resection because of
a solitary, hypervascular and homogeneous mass located in close
se.proximity to the head of the pancreas, measuring 16 mm.  Pathology
showed a metastatic clear cell renal carcinoma, with free surgical
margins. The patient was thereafter asymptomatic until December
2011, when she noted a quickly enlarging lump in the right breast.
 Ltd. Open access under CC BY-NC-ND license.
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Fig. 1. Preoperative imaging. Top: ultrasound showing a hypoechoic homoge-
neous  solid nodule with posterior acoustic enhancement (yellow gallons) and color
Doppler showing peripheral and penetrating vascular network. Bottom: contrast-
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Fnhanced axial computed tomography image of the chest show an enhancing,
omogeneous  right breast mass (red arrow). (For interpretation of the references to
olor in this ﬁgure legend, the reader is referred to the web  version of the article.)
On admission, clinical examination revealed a palpable and
obile mass in the upper inner quadrant of the right breast with
n enlarged ipsilateral axillary lymph node; no skin or nipple
etraction were noticed. A mammogram showed a dense well
ircumscribed solid mass, not spiculate, measuring 3 cm in diam-
ter, with no adjacent parenchymal distortion and no sign of
icrocalciﬁcation; there were no signs of inﬁltration of the skin.
onography showed a hypoechoic homogeneous solid nodule with
o posterior attenuation of the acoustic wave but with promi-
ent peripheral vascularity and penetrating vessels detected at
olor and power Doppler. The adjacent parenchyma was just dis-
laced without obvious distortion, again with no skin thickening
r duct ectasia. Multiple subcentimetric axillary lymphnodes were
resent, with a single one measuring 2 cm in diameter, with a pre-
erved architecture. A contrast-enhanced whole body CT showed
n enhancing, homogeneous right breast mass (Fig. 1), and ﬁne
eedle aspiration citology (FNAC) was unable to show malignancy.
 tru-cut biopsy was then performed and revealed a tumor com-
osed of nests and cords of cells with clear cytoplasm separated by
 prominent sinusoidal vascular network (Fig. 2), which showed, at
ig. 2. Histology (H&E, 5×) clear cell carcinoma (left) metastatic to the breast (right).Fig. 3. Gross anatomy of metastasis to the breast from Renal Cell Carcinoma (RCC);
see text for description.
immunohistochemistry, positive vimentin and CD10 staining while
CK7 and CK20 were negative. Such pattern was  consistent with
Renal Cell Carcinoma of clear cell type (Fig. 3). After a multi-
disciplinary discussion, the patient underwent metastasectomy
and exeresis of the largest palpable axillary lymph node, that
resulted unaffected at frozen section. The postoperative course was
uneventful and no further adjuvant treatment was performed.
3.  Discussion
The breast is a rare site of metastatic deposits, as emerges from
the small number of cases reported in the literature. However, it
is possible that the incidence of such ﬁnding will become more
and more frequent because of the increasing number of patients
who live longer bearing malignant disease.18 In facts, the 5-year
and 10-year survival rates for the patients with RCC treated with
nephrectomy are 95% and 91% for pT1; 80% and 70% for pT2; 66%
and 53% for pT3a; 52% and 43% for pT3b; and 43 and 42% for pT3c,
respectively.19 Metastases can take place either in a synchronous
or metachronous fashion with respect to the primary tumor: out
of 25 cases reported in the literature, 14 actually occurred after
nephrectomy for RCC. A former history of RCC should therefore
arouse suspicion of metastatic escape to the breast despite the fact
that primary carcinoma of the breast is much more common.10,20
Bowditch et al. reported a majority of metachronous presen-
tation, that was  claimed to carry a better prognosis than the
synchronous metastases21; however, to the best of our knowledge,
no strong evidence of a signiﬁcant prognostic difference between
metachronous and synchronous presentations can be argued from
the data available in the literature.
Clinically, metastatic lesions in the breast present as painless
and mobile discrete masses with rapid growth. The skin is usually
not affected and axillary lymph node involvement is variable.9,22
One case reported the presence of a metastatic lymphnode.4
The ﬁndings of the traditional diagnostic workup most likely
mimic  a benign breast mass, due to the absence of desmoplas-
tic reaction; in particular the deposits of malignant cells do not
show spiculation or microcalciﬁcation on the mammogram and
the sonography does not reveal posterior attenuation of the ultra-
sounds. The only ﬁnding that can be suggestive of malignancy is
the prominent peripheral and penetrating vascular network, well
evident to color and power Doppler, that is common to all cases
reported in the literature.Awareness  of a former treatment for RCC should lead to stress
the preoperative diagnosis because the treatment of breast sec-
ondary lesions differs from that of primary breast tumors, either
as far as the lumpectomy margins width and the management of
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xillary lymph nodes are concerned. In facts, the malignant exten-
ion to the breast can be explained by the spread of neoplastic cells
rom the renal vein into the inferior vena cava and then through
he pulmonary circulation, eventually reaching the arterial circu-
ation, diffusing throughout the whole body and thereby reaching
he breast: therefore, the high rate of multiple lesions23 that consti-
utes the rationale of the efforts aimed at obtaining wide tumor-free
argins is pointless in secondary disease. Besides, the mechanism
f metastatic diffusion renders the the biopsy of a sentinel lymph
ode void of sense in such cases; since malignant cells reach the
reast (via ematogenous spread), sampling the efferent lympha-
ics that constitute a way of diffusion from the breast is pointless.
oreover, the staging role of SLNB obviously only applies to pri-
ary tumors, while sampling breast loco-regional lympnodes for
umors originating elsewhere in the body makes no sense.
In  cases of metastatic RCC, citology may  show atypical cells
hich differ from those of a primary breast tumor24 but which,
n the other hand, are frequently reported as benign.7 A diagno-
is based on histopathological investigation is therefore crucial in
rder to avoid an unnecessary mastectomy with sentinel lymph-
ode biopsy (or primary axillary dissection). Moreover, we suggest
o avoid FNAC for the additional reason that the vascular network
hat characterizes metastases from RCC may  lead to a high false-
egative rates.
.  Conclusions
In conclusion, we suggest to consider a micro-histological
iopsy  of any new breast lesion appearing in a patient with a his-
ory of treatment for RCC as mandatory. A whole body CT scan
ay be included in the staging work-up. In the case of an isolated
esion, metastasectomy is the treatment of choice; axillary lymph
odes should be removed only in cases of overt metastatic depo-
ists. So far, unfortunately, no effective adjuvant therapeutic option
s available for disseminated RCC25 because of the great resistance
o chemotherapy and radiotherapy of this kind of metastases.
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